In summary, we developed an avidity‐based capture platform that enables high‐affinity and selective detection of PD‐L1‐expressing exosomes, addressing key limitations of conventional exosome detection strategies, such as insufficient sensitivity and limited ability to distinguish tumor‐derived vesicles. Here, CD274 is linked to neoplasm.